The Predictive Value of Red Blood Cell Distribution Width for Survival Outcomes of Metastatic Renal Cell Carcinoma Patients Treated with Targeted Therapy-Reference-Cited by-同舟云学术

The Predictive Value of Red Blood Cell Distribution Width for Survival Outcomes of Metastatic Renal Cell Carcinoma Patients Treated with Targeted Therapy

Published:2021-01-25 Issue:10 Volume:73 Page:1957-1963
ISSN:0163-5581
Container-title:Nutrition and Cancer
language:en
Short-container-title:Nutrition and Cancer

Author:

Aktepe Oktay Halit¹^ORCID,Guven Deniz Can¹,Sahin Taha Koray²,Yildirim Hasan Cagri¹,Celikten Burcu²,Yeter Haci Hasan³,Yuce Deniz⁴^ORCID,Dizdar Omer⁴,Erman Mustafa⁴

Affiliation:

1. Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey

2. Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey

3. Department of Nephrology, Faculty of Medicine, Gazi University, Ankara, Turkey

4. Department of Preventive Oncology, Hacettepe University Cancer Institute, Ankara, Turkey

Publisher

Informa UK Limited

Subject

Cancer Research,Nutrition and Dietetics,Oncology,Medicine (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/01635581.2021.1871925

Reference27 articles.

1. Renal cancer

2. Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study

3. Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations;Clinical & Experimental Metastasis;2024-02-16

2. External Validation of a Red Cell-based Blood Prognostic Score in Patients With Metastatic Renal Cell Carcinoma Treated With First- Line Immunotherapy Combinations;2023-10-10

3. The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospective study;Therapeutic Advances in Urology;2023-01

4. Pretreatment red blood cell distribution width may be a potential biomarker of prognosis in urologic cancer: a systematic review and meta-analysis;Biomarkers in Medicine;2022-12

5. Red blood cell distribution width and renal cell carcinoma: A comparative analysis of peer-reviewed studies;Translational Oncology;2022-12